On Cancer

and/or

84 Blog posts found

Feature

Meet the Scientists Who Engineer CAR T Cells, a Type of "Living" Immunotherapy

An immunotherapy called CAR T is transforming the treatment of certain cancers. These are the people who make it possible.

MSK cell manufacturing specialist Xiuyan Wang

Q & A

Meet Matthew Matasar, Chief of the Medical Oncology Service at MSK Bergen

Get to know Matthew Matasar, the new Chief of the Medical Oncology Service at MSK Bergen.

MSK medical oncologist Matthew Matasar

Finding

Discovery of Unusual Cell Type Could Help Guide Immunotherapy

A newly identified group of immunosuppressive cells could provide insight into the effects of immunotherapy drugs.

Scanning electron micrograph (SEM) of T lymphocyte cells (blue) attached to a red cancer cell.

Roundup

Highlights from ASCO 2018: Immunotherapy for Endometrial Cancer, Benefits of Exercise, and Promising New Targeted Drugs

Couldn't make it to the American Society of Clinical Oncology's annual meeting this year? Read this summary of some main takeaways.

Crowded hall with ASCO signage

In the Clinic

CAR Therapy for Solid Tumors Passes Early Milestone

Preliminary results from a clinical trial indicate that an experimental CAR therapy for mesothelioma is safe.

Immunofluorescence staining of human lung cancer showing mesothelin (pink) on cancer cells and human T cells (green).

In the Clinic

Immunotherapy Combination Is Better than Chemotherapy for Non-Small Cell Lung Cancer

MSK’s Matthew Hellmann led an international, phase III trial looking at the combination of immunotherapy drugs ipilimumab and nivolumab.

MSK medical oncologist Matthew Hellmann

In the Clinic

Immunotherapy Drug Shows Promise for Metastatic Merkel Cell Carcinoma

An immunotherapy drug might be an effective initial treatment for people with metastatic Merkel cell carcinoma.

Dermatologist examining skin on the face of older man.